Monday, May 3, 2021

Natco gets CDSCO nod for emergency use of Baricitinib tablets for COVID-19 treatment

Natco gets CDSCO nod for emergency use of Baricitinib tablets for COVID-19 treatment CDSCO is responsible for approval of drugs, conduct of clinical trials, laying down the standards for drugs, control over the quality of imported drugs in the country and coordination of the activities of state drug control organisations.

from Moneycontrol Business News https://ift.tt/3xL3DiC

No comments:

Post a Comment

Apollo Micro Systems shares surge 15% following Rs 25 cr order wins from DRDO, other defence PSUs

Apollo Micro Systems shares saw a significant rise. The company secured orders worth Rs 25.12 crores from DRDO and Defence PSUs. This news b...